E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/31/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Cardima raises additional $1 million in convertible bridge loan

By Sheri Kasprzak

New York, Aug. 31 - Cardima, Inc. said it has raised another $1 million from a convertible bridge loan it received from Apix International Ltd., bringing to $3 million the total proceeds realized from the offering.

The loan matures in three months, bears interest at 10% and is convertible into common shares at $0.10 each.

Apix will receive warrants for 30 million shares, exercisable at $0.10 each.

The company has received $1 million in proceeds from the deal already and will receive another $500,000 on Sept. 12; $500,000 on Oct. 12; $350,000 on Nov. 18; $350,000 on Dec. 18 and $300,000 on Jan. 18, 2006.

The company initially raised $2 million from the deal closed on Aug. 28.

A portion of the proceeds will be used to retire an existing loan facility with Agility Capital, LLC. The remainder will be used for working capital.

Based in Fremont, Calif., Cardima develops microcatheter systems used to treat atrial fibrillation.

Issuer:Cardima, Inc.
Issue:Convertible bridge loan
Amount:$3 million
Maturity:Three months
Coupon:10%
Price:Par
Yield:10%
Conversion price:$0.10
Warrants:For 30 million shares
Warrant strike price:$0.10
Settlement date:Aug. 31
Stock price:$0.10 at close Aug. 30

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.